AstraZeneca announces winners of the 2023 R&D Postdoctoral Challenge

AstraZeneca announced today eight winners of the 2023 R&D Postdoctoral Challenge and agreed to fund their postdoctoral positions at one of the Company’s strategic R&D centres in either Cambridge, UK, Gaithersburg or Boston, US or Gothenburg, Sweden.

Rare disease biotech Rallybio cuts 19 staffers and sheds partnered preclinical programs

Rallybio is laying off close to half of its employees and seeking “alternative options” for its preclinical programs as it gets ready to put the

February 7, 2024

Psychedelic Harm Reduction and Integration: Empowering the Psychedelic Community | Psychedelic Invest

Harm reduction and integration for people choosing to use psychedelics is important for both safety and maximization of benefits. Simply put, psychedelic harm reduction is

September 6, 2023

VA Awards $1.5M To Study MDMA for PTSD | Psychedelic Invest

Veterans Affairs officials announced on Tuesday a $1.5 million grant to explore MDMA-assisted therapy as a treatment for post-traumatic stress disorder (PTSD) and alcohol use

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.